Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review.

Hariprasad SM, Holz FG, Asche CV, Issa A, Mora O, Keady S, Rezk MF, Sarocco P, Simoens S.

Open source

DOI
10.1007/s40123-025-01104-3
Published
2025-02-26
Container
Ophthalmol Ther
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40123-025-01104-3,
  title = {Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review.},
  author = {Hariprasad SM and  Holz FG and  Asche CV and  Issa A and  Mora O and  Keady S and  Rezk MF and  Sarocco P and  Simoens S.},
  year = {2025},
  journal = {Ophthalmol Ther},
  doi = {10.1007/s40123-025-01104-3},
  url = {https://doi.org/10.1007/s40123-025-01104-3}
}

RIS

TY  - JOUR
TI  - Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review.
AU  - Hariprasad SM
AU  -  Holz FG
AU  -  Asche CV
AU  -  Issa A
AU  -  Mora O
AU  -  Keady S
AU  -  Rezk MF
AU  -  Sarocco P
AU  -  Simoens S.
PY  - 2025
JO  - Ophthalmol Ther
DO  - 10.1007/s40123-025-01104-3
UR  - https://doi.org/10.1007/s40123-025-01104-3
ER  - 

APA

SM, H., FG, H., CV, A., A, I., O, M., S, K., MF, R., P, S., & S., S. (2025). Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review.. Ophthalmol Ther. https://doi.org/10.1007/s40123-025-01104-3

Source records